1 Mandel L. Salivary Gland Disorders. Med Clin North Am. 2014; 98(6):1407–49.
2 Jent P, Berger C, Streit S, Sommerstein R, Les oreillons: de l’histoire ancienne? Forum Méd Suisse. 2018;18(41):832–5.
3 Geraint J, Sharma P, Parotid gland sarcoidosis. Sarcoidosis vasculitis and diffuse Lung diseases. 2000;17:27–32.
4 Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006;174: 795–802.
5 Spagnola P, Rossi G, Trisolini R, Sverzellati N, Baughmann R, Wells A, Pulmonary sarcoidosis. Lancet Respir Med. 2018;6:389–402.
Références supplémentaires
6 Mandel L, Surattanont F, Bilateral Parotid swelling: A Review. Oral surgery, oral medicin, oral pathology. 2002;93:221–37.
7 Longo N, Ghaderi M, Primary Parotid gland sarcoidosis: Case report and discussion of diagnosis and treatment. Ear Nose Throat Journal. 2010;89(4):E6–10.
8 King T, Flatherty K, Hollingsworth K, Clinical manifestations and diagnosis of pulmonary sarcoidosis. UpToDate. 2018.
9 Iannuzzi MC, Rybicki B, Terstein AS, Sarcoïdosis. N Engl J Med. 2007;357:2153–65.
10 Baughman RB, Grutters JC, New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches.Lancet Respir Med. 2015;3:813–22.
11 Lyko C, Bart PA, Pruvot E, Prior J, Waeber G, Sarcoidose extrapulmonaire: entité méconue? Rev Méd Suisse. 2010;6:2056–60.